Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Amneal Pharmaceuticals is a US-based, globally operating pharmaceutical company. It focuses on the development, manufacturing, and distribution of high-quality generics, specialty pharmaceuticals, and biosimilars. Amneal contributes to improving patient care worldwide with innovative and affordable medication solutions.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Amneal Pharmaceuticals is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Amneal Pharmaceuticals last reported quarterly earnings on 7/30/2026 (Q2 2026). Earnings per share (EPS) came in at 0.30 USD.
Across its last 3 earnings reports, Amneal Pharmaceuticals stock moved by ±3% on average the following day. The largest reaction was -4.7% on 02/27/2026; 0 of 3 reactions were positive.
Amneal Pharmaceuticals has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.